Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Study design of PANGAEA 2.0, a non-interventional study on RRMS patients to be switched to fingolimod.
Pharmacological targeting of the PDGF-CC signaling pathway for blood-brain barrier restoration in neurological disorders.
[Improving the sexual quality of life of people with multiple sclerosis].
Neuromyelitis optica spectrum disorder coinciding with hematological immune disease: A case report.
In Vivo Gene Transfer to Schwann Cells in the Rodent Sciatic Nerve by Electroporation.
Comparative effectiveness using a matching-adjusted indirect comparison between delayed-release dimethyl fumarate and fingolimod for the treatment of multiple sclerosis.
Immunotherapy Improves Cognitive Function in Secondary Progressive Multiple Sclerosis.
Calcium Signalling Triggered by NAADP in T Cells Determines Cell Shape and Motility During Immune Synapse Formation.
Whole-Genome DNA Methylation Analysis of Peripheral Blood Mononuclear Cells in Multiple Sclerosis Patients with Different Disease Courses.
Letter to the Editor: The Emerging Role of Pharmacists in the Multidisciplinary Care of Patients with Multiple Sclerosis.
Treatment of multiple sclerosis by transplantation of neural stem cells derived from induced pluripotent stem cells.
Subcortical grey matter volumes predict subsequent walking function in early multiple sclerosis.
Systematic Review of the Neurobiological Relevance of Chemokines to Psychiatric Disorders.
Altered Mitochondrial Dynamics Contributes to Propofol-induced Cell Death in Human Stem Cell-derived Neurons.
Classroom demonstration of the visual effects of eye diseases.
Efficacy and safety of a three-times-weekly dosing regimen of glatiramer acetate in relapsing-remitting multiple sclerosis patients: 3-year results of the Glatiramer Acetate Low-Frequency Administration open-label extension study.
Deimination of the myelin basic protein decelerates its proteasome-mediated metabolism.
Characterization of IL-17AA and IL-17FF in rheumatoid arthritis and multiple sclerosis.
Cre inducible site-specific recombination in zebrafish oligodendrocytes.
Monoclonal Antibody Therapy for Neuromyelitis Optica Spectrum Disorder: Current and Future.
Changes in the Expression of miR-34a and its Target Genes Following Spinal Cord Injury In Rats.
Dual inhibition of proteasomal and lysosomal proteolysis ameliorates autoimmune central nervous system inflammation.
Postreading Self-Assessment and CME Test.
Aquaporin-4 IgG autoimmune syndrome and immunoreactivity associated with thyroid cancer.
Mycophenolate Mofetil as a Monotherapy in Multiple Sclerosis: a multicentre retrospective study on 361 patients
Pages
« first
‹ previous
…
789
790
791
792
793
794
795
796
797
…
next ›
last »